Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026

Core Insights - Daxor Corporation will participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026, with CEO Michael Feldschuh presenting on March 10 at 2:00 PM ET [1] - The company focuses on addressing the critical issue of accurately measuring blood volume, which is essential for improving patient care and reducing hospital stays for conditions like heart failure [2] Company Overview - Daxor Corporation is a leader in blood volume measurement technology, offering a patented, FDA-cleared Blood Volume Analysis (BVA) diagnostic system that provides real-time, precise data [2] - The company has 50 years of experience and operates a state-of-the-art 20,000-square-foot manufacturing facility in the U.S., positioning it for market expansion [2] - Daxor's technology aims to enhance individualized treatment decisions, thereby improving patient outcomes and increasing efficiencies in value-based healthcare [2]